title: Coronary myocardial bridge constitutes a risk: But how to manage it?
abstract: Myocardial bridges may cause angina pectoris, myocardial infarction, life threatening arrhythmias and even sudden cardiac death but most of them are harmless. Although the exact management is not well known, beta blockers seem to be the first choice. Stenting is controversial and one must think "twice" before stenting the bridged coronary artery.
authors: Cem
authors: C
authors: Barcin
authors: Hurkan
authors: H
authors: Kursaklioglu
authors: Sedat
authors: S
authors: Kose
authors: Basri
authors: B
authors: Amasyali
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D015906:Angioplasty, Balloon, Coronary; D006801:Humans; D054084:Myocardial Bridging / Q000188:drug therapy* / Q000453:epidemiology*; D012307:Risk Factors; D015607:Stents
chemical_list: D000319:Adrenergic beta-Antagonists